Live Breaking News & Updates on Brian David Archbold

Stay updated with breaking news from Brian david archbold. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Mesa Laboratories (NASDAQ:MLAB) Upgraded to "Outperform" at Evercore ISI

Mesa Laboratories (NASDAQ:MLAB – Get Free Report) was upgraded by equities research analysts at Evercore ISI from an “in-line” rating to an “outperform” rating in a research report issued on Thursday, Briefing.com reports. The brokerage currently has a $125.00 price target on the medical instruments supplier’s stock, up from their previous price target of $100.00. […] ....

United States , Asia Pacific , Brian David Archbold , Comerica Bank , Biopharmaceutical Development , Securities Exchange Commission , Morgan Stanley , Citadel Advisors , Mesa Laboratories Inc , Glenmede Trust Co , Mesa Laboratories Company Profile , Calibration Solutions , Mesa Laboratories , Get Free Report , David Archbold , Exchange Commission , North America , Clinical Genomics , Disinfection Control , Mesa Laboratories Daily , Nasdaq Mlab , Evercore Isi ,

Mesa Laboratories, Inc. (NASDAQ:MLAB) SVP Brian David Archbold Sells 1,500 Shares

Mesa Laboratories, Inc. (NASDAQ:MLAB – Get Free Report) SVP Brian David Archbold sold 1,500 shares of the firm’s stock in a transaction that occurred on Friday, December 15th. The stock was sold at an average price of $112.36, for a total value of $168,540.00. Following the completion of the sale, the senior vice president now […] ....

Hong Kong , United States , Brian David Archbold , Asia Pacific , Tower Research Capital , Calibration Solutions , Mesa Laboratories Inc , Cubist Systematic Strategies , Biopharmaceutical Development , Hong Kong Ltd , Mesa Laboratories , Get Free Report , David Archbold , Kong Ltd , Zentral Genossenschafts Bank Frankfurt , Research Capital , North America , Clinical Genomics , Disinfection Control , Mesa Laboratories Daily , Nasdaq Mlab , Insider Trading , Nsider Trades ,